ReviewReviews in cardiovascular medicine2026

A New Option for the Management of Dyslipidemias: Advances in Research on the Small Interfering RNA Drug Inclisiran.

Xuebing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.